Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Omid Hamid | Researchclopedia

Back to researchers

Omid Hamid

Northern Border University ORCID

858

Works

83,388

Citations

96

h-index

313

i10-index

Research Topics

Cancer Immunotherapy and Biomarkers Immunotherapy and Immune Responses CAR-T cell therapy research

Affiliations

Université Paris-Sud2017–2017

Rutgers, The State University of New Jersey2016–2016

Northwestern University2012–2014

University of Southern California2006–2006

Northern Border University2025–2025

Top Works

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

Julie R. Brahmer,Scott S. Tykodi,et al.

20127,944 citations

Melanoma and MAPK Pathways

Immune cells in cancer

Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer

Edward B. Garon,Naiyer A. Rizvi,et al.

20156,161 citations

Pembrolizumab versus Ipilimumab in Advanced Melanoma

Caroline Robert,Jacob Schachter,et al.

20155,785 citations

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

Roy S. Herbst,Jean‐Charles Soria,et al.

20145,219 citations

Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma

Omid Hamid,Caroline Robert,et al.

20133,386 citations

Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria

Jedd D. Wolchok,Axel Hoos,et al.

20093,206 citations

Combined BRAF and MEK Inhibition in Melanoma with BRAF V600 Mutations

Keith T. Flaherty,J. Infante,et al.

20122,786 citations

Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma

Dirk Schadendorf,F. Stephen Hodi,et al.

20152,105 citations

Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial

Caroline Robert,Antoni Ribas,et al.

20141,754 citations